Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · October 16, 2024

Feasibility of Dose Spacing of IL-23 Inhibitors Among Patients With Psoriasis

American Journal of Clinical Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Clinical Dermatology
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis
Am J Clin Dermatol 2024 Sep 27;[EPub Ahead of Print], M Luz, T Torres

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading